Health Trials

B7-H3-positive Relapsed/ Refractory Neuroblastoma

1

Review clinical trials related to B7-H3-positive Relapsed/ Refractory Neuroblastoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma

Phase I clinical trials are designed as open-label, dose-escalation and dose-expansion clinical studies, the main purpose of which is to explore the tolerability, safety, cytokinetic characteristics and RP2D and preliminary observation of the efficacy of the study drug in subjects with B7-H3-positive relapsed/refractory neuroblastoma.

Participants needed: 24
Trial details
Phase: Phase 1Age: 1+Biological sex: AllType: InterventionalSponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.Updated: Feb 27, 2023Locations: 2
Eligibility criteria

Age ≥ 1 year (including cut-off value), gender is not limited [+13]

Patients who were judged by the investigator to require long-term immunosuppress... [+15]

Read more